Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.360
-0.010 (-0.73%)
At close: Feb 21, 2025, 4:00 PM
1.350
-0.010 (-0.71%)
After-hours: Feb 21, 2025, 6:48 PM EST
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $2.59 million as of February 21, 2025. Its market cap has increased by 11.96% in one year.
Market Cap
2.59M
Enterprise Value
-517.72K
1-Year Change
11.96%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $11.31B to $2.59M, a decrease of -99.98%. That is a compound annual growth rate of -86.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 2.59M | -28.83% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.74% |
| Dec 31, 2020 | 11.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |